Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.408,09
-1,42%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anika Therapeutics Inc (ANIK) Anika Therapeutics Inc (ANIK) Notizie

Anika Therapeutics Inc

ANIK
26,49
0,60 (2,32%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202422:01GLOBEAnika to Issue First Quarter 2024 Financial Results on..
02/4/202414:00GLOBEAnika to Participate in the 23rd Annual Needham Virtual..
13/3/202421:05GLOBEAnika Reports Fourth Quarter and Year-End 2023 Financial..
13/3/202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
08/3/202422:01GLOBEAnika Reports Inducement Grants Under Nasdaq Listing Rule..
07/3/202401:30EDGAR2Form SC 13D/A - General statement of acquisition of..
27/2/202422:01GLOBEAnika to Issue Fourth Quarter and Year-End 2023 Financial..
26/2/202415:00EDGAR2Form 8-K - Current report
13/2/202415:00GLOBEAnika Highlights Its Recently Launched Integrity™ Implant..
09/2/202417:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202415:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202422:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202422:35EDGAR2Form 3/A - Initial statement of beneficial ownership of..
28/11/202315:00GLOBEAnika Announces First Surgeries Performed using the..
07/11/202322:05GLOBEAnika to Participate in Upcoming Investor Conferences
02/11/202321:11EDGAR2Form 8-K - Current report
02/11/202321:05GLOBEAnika Reports Third Quarter 2023 Financial Results and..
10/10/202315:00GLOBEAnika to Issue Third Quarter 2023 Financial Results on..
03/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202313:55EDGAR2Form 8-K - Current report
19/9/202315:00GLOBEAnika Announces the Full Market Release of the RevoMotion™..
15/9/202322:01GLOBEAnika Reports Inducement Grants Under Nasdaq Listing Rule..
12/9/202315:00GLOBEAnika to Participate in the Sidoti Small Cap Virtual..
11/9/202312:01EDGAR2Form SC 13D/A - General statement of acquisition of..
02/9/202300:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
18/8/202301:57DJNAnika Rotator-Cuff Treatment May Launch in 1Q Following..
18/8/202300:20GLOBEAnika Receives 510(k) Clearance for Integrity™ Implant..
17/8/202314:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202323:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:11EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEAnika Reports Second Quarter 2023 Financial Results
20/7/202322:05GLOBEAnika to Issue Second Quarter 2023 Financial Results on..
12/7/202315:00GLOBEAnika Showcases Highly Differentiated Joint Preservation and..
30/5/202322:05GLOBEAnika Completes Enrollment in Hyalofast® U.S. Pivotal Phase..
09/5/202322:05GLOBEAnika Reports First Quarter 2023 Financial Results
Apertura: 25,96 Min: 25,96 Max: 26,57
Chiusura: 25,89

La tua Cronologia

NASDAQ
ANIK
Anika Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network